Marker Therapeutics, Inc. Common Stock MRKR

$1.54 +2.67% at last close

Analyst Consensus

Consensus Rating
Buy (1 Buy · 0 Hold · 0 Sell)
Average Price Target
$10.00
Implied Upside
+549.4%
Price Target Range
$10.00 – $10.00
Analysts (12 mo)
1

Recent Analyst Actions

DateFirmActionRatingPrice Target
2025-12-08
HC Wainwright & Co.Patrick R. Trucchio
 Initiates coverage on Buy $10
2025-04-01
WBB SecuritiesSteve Brozak
 Reiterates Strong buy $13
2025-03-05
Canaccord GenuityJohn Newman
 Initiates coverage on Buy $8
2024-10-21
Ladenburg ThalmannAydin Huseynov
 Maintains Buy $11 → $19
2024-04-30
Ladenburg ThalmannAydin Huseynov
 Initiates coverage on Buy $11
2022-02-17
Roth CapitalTony Butler
 Downgrades Buy → Neutral $30 → $10
2021-03-25
Piper SandlerJoseph Catanzaro
 Initiates coverage on Overweight $60
2021-03-19
Cantor FitzgeraldKristen Kluska
 Initiates coverage on Overweight $60
2021-03-18
Cantor FitzgeraldKristen Kluska
 Initiates coverage on Overweight $60
2020-05-12
Piper SandlerEdward Tenthoff
 Downgrades Overweight → Neutral $50 → $25
2019-11-13
Piper SandlerEdward Tenthoff
 Maintains Overweight $100 → $60
2019-11-13
Janney Montgomery Scott
 Maintains Buy $150 → $100
2019-07-03
Oppenheimer
 Initiates coverage on Outperform $150
2019-05-30
Roth CapitalTony Butler
 Initiates coverage on Buy $100
2019-03-29
WBB Securities
 Upgrades Buy → Strong buy —
2019-03-01
Janney Montgomery Scott
 Initiates coverage on Buy $62

Ratings and price targets reflect each firm's most recent published action. Consensus combines the latest call from every covering firm over the past 12 months; price targets are typically 12-month horizons.

Key Stats

Last Close
$1.54
Market Cap
$25.01 million
52-Week Range
$0.81 – $2.46
Average Volume
62K shs

Data is delayed and provided for informational purposes only. Not investment advice. See our disclaimer.